Register NOW to be notified when the investment window opens!
We are currently making potential investors aware of an upcoming opportunity to support the development of RSBT-001 for respiratory diseases characterized by pulmonary inflammation, including Chronic Obstruction Pulmonary Disease (COPD) and Idiopathic Pulmonary Fibrosis (IPF). If you would like to receive more information about investment opportunities, please fill out the interest registration form at the bottom of this page and you will receive an email as soon as the investment offering launches.
Please complete the short interest form below and a representative will contact you soon.
RS BioTherapeutics is currently preparing for our Regulation Crowdfunding raise, on the Start Engine portal. As such (1) No money or other consideration is being solicited, and if sent in response, will not be accepted; (2) no offer to buy the securities can be accepted and no part of the purchase price can be received until the offering statement is filed and only through Start Engine’s platform; and (3) a prospective purchaser's indication of interest involves no obligation or commitment of any kind. “Reserving” securities is simply an indication of interest.
